Svenningsson P, Fredholm B B
Department of Physiology and Pharmacology, Section of Molecular Neuropharmacology, Karolinska Institutet, Stockholm, Sweden.
J Pharmacol Exp Ther. 1997 Feb;280(2):1094-101.
The effect of adrenalectomy on the expression of adenosine receptors and their mRNA in rat brain was examined using quantitative autoradiography and in situ hybridization. 1,3-[3H]Dipropyl-8-cyclopentylxanthine ([3H]DPCPX), a selective adenosine A1 receptor antagonist, and [3H]CGS 21680, a selective adenosine A(2A) receptor agonist, were used as radioligands. One week after adrenalectomy, the expression of mRNA for adenosine A1 receptors was significantly decreased, as was the number of binding sites for [H]DPCPX. These effects were significantly counteracted by replacement treatment with dexamethasone (1.5 mg/kg i.p., twice daily). Addition of GTP caused a similar increase of [3H]DPCPX binding in sham-operated rats, adrenalectomized rats and rats adrenalectomized and treated with dexamethasone. Moreover, no differences in displacement of [3H]DPCPX by the adenosine receptor agonist N6-(R-phenylisopropyl)adenosine were found among these groups. Adrenalectomy did not significantly affect the number of [3H]CGS 21680 binding sites in striatum or the mRNA encoding adenosine A(2A) receptors. No changes in the affinity of [3H]CGS 21680 for adenosine A(2A) receptors or in the potency of the adenosine receptor agonist 2-chloroadenosine to displace [3H]CGS 21680 were found. Dexamethasone treatment decreased cAMP formation induced by the nonselective adenosine agonist 5'-N-ethylcarboxamidoadenosine in Jurkat cells, which express adenosine A(2B) receptors, but did not alter it in PC-12 cells, which express mostly A(2A) receptors. The results suggest that endogenous corticosteroids positively regulate the expression of adenosine A1 receptors, at least partly at the transcriptional level. In contrast, corticosteroids do not regulate the expression of adenosine A(2A) receptors.
采用定量放射自显影术和原位杂交技术,研究了肾上腺切除术对大鼠脑内腺苷受体及其mRNA表达的影响。使用选择性腺苷A1受体拮抗剂1,3-[3H]二丙基-8-环戊基黄嘌呤([3H]DPCPX)和选择性腺苷A(2A)受体激动剂[3H]CGS 21680作为放射性配体。肾上腺切除术后一周,腺苷A1受体mRNA的表达显著降低,[H]DPCPX的结合位点数量也显著减少。地塞米松(1.5mg/kg腹腔注射,每日两次)替代治疗可显著抵消这些作用。添加GTP后,假手术大鼠、肾上腺切除大鼠以及肾上腺切除并用糖皮质激素治疗的大鼠中,[3H]DPCPX结合均有类似增加。此外,在这些组中,腺苷受体激动剂N6-(R-苯异丙基)腺苷对[3H]DPCPX的置换作用没有差异。肾上腺切除术对纹状体中[3H]CGS 21680结合位点的数量或编码腺苷A(2A)受体的mRNA没有显著影响。未发现[3H]CGS 21680对腺苷A(2A)受体的亲和力或腺苷受体激动剂2-氯腺苷置换[3H]CGS 21680的效力有变化。地塞米松治疗可降低表达腺苷A(2B)受体的Jurkat细胞中由非选择性腺苷激动剂5'-N-乙基甲酰胺基腺苷诱导的cAMP生成,但对主要表达A(2A)受体的PC-细胞没有影响。结果表明,内源性皮质类固醇至少部分在转录水平上正向调节腺苷A1受体的表达。相比之下,皮质类固醇不调节腺苷A(2A)受体的表达。